Abiopharma

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001839882-26-039783 <b>Size:</b> 1 MB

New Form SCHEDULE 13G/A - Acrivon Therapeutics, Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001875620-26-000015 <b>Size:</b> 17 KB

(30% Negative) OVID THERAPEUTICS INC. (OVID) Reports Q3 2026 Financial Results

(10% Negative) FATE THERAPEUTICS INC (FATE) Reports Q3 2026 Financial Results

Ovid Therapeutics Inc. - Ovid Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results

Response to SGX Queries:

(30% Negative) HEARTCORE ENTERPRISES, INC. (HTCR) Reports Q3 2026 Financial Results

(99% Positive) TRON INC. (TRON) Announces Business Combination

(30% Negative) FITLIFE BRANDS, INC. (FTLF) Reports Q3 2026 Financial Results

(30% Negative) SS INNOVATIONS INTERNATIONAL, INC. (SSII) Reports Q3 2026 Financial Results

Bed Bath &amp; Beyond, Inc. Appoints Jill Windrum as Chief Accounting Officer and Deputy Chief Financial Officer

Satellogic Appoints Jamil Kawar as Senior Vice President, Space Systems

TechForce Robotics Signs LOI with NBR Intelligence for Potential Deployment of Up to 5,000 Robotic Systems

Live Ventures Reports Fiscal Third Quarter 2026 Financial Results

SAIC Schedules Second Quarter Fiscal Year 2027 Earnings Conference Call for August 31 at 10 A.M. EDT